Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar;30(1):37-45.
doi: 10.5152/balkanmedj.2012.071. Epub 2013 Mar 1.

Long-Term Effects of Antibodies against Human Leukocyte Antigens Detected by Flow Cytometry in the First Year after Renal Transplantation

Affiliations

Long-Term Effects of Antibodies against Human Leukocyte Antigens Detected by Flow Cytometry in the First Year after Renal Transplantation

Tülay Kılıçaslan Ayna et al. Balkan Med J. 2013 Mar.

Abstract

Objective: In this study, we aimed to investigate the incidence, dynamics and profiles of human leukocyte antigen (HLA)-directed antibodies developed after transplantation and their impact on graft rejection and outcome in kidney recipients.

Study design: Prospective follow-up study.

Material and methods: A total of 56 kidney recipients were monitored at 1(st), 6(th) and 12(th) months for the development of anti-HLA antibodies using bead based flow-cytometry assays (Flow PRA tests).

Results: In 21 (37.5%) patients, panel reactive antibodies (PRA) was positive after transplantation, however, in 35 (62.5%) patients PRA was found negative. Twelve (57.1%) patients with post-transplantation HLA-reactive antibodies [PRA (+)] and 8 (22.9%) patients with no detectable alloantibodies [PRA (-)] were developed allograft rejection (p=0.010). In the PRA positive patient group the rates of early period infection and delayed graft function (DGF) were higher than the PRA negative patient group. Serum creatinine levels of PRA positive group at 6. and 12. months after transplantation were significantly higher than the PRA negative group (p=0.015 and p=0.048, respectively). The rejection rates of patients who had class I and II HLA antibodies were significantly higher than the patients who had either class I or II HLA antibodies (p=0.011). Acute rejection rates were significantly higher in patients who had class I and II HLA antibodies at the first month (p=0.007).

Conclusion: Higher occurrence of rejection episodes in PRA positive group may show the importance of anti-HLA antibody monitoring using Flow-PRA after renal transplantation as a prognostic marker in terms of graft survival.

Keywords: Anti-HLA antibodies; flow cytometry; renal transplantation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Relation between rejection and the rates of PRA positive and negative groups
Figure 2.
Figure 2.
Relation between rejection and the rates of transiently or permenantly positive PRAs

References

    1. Mihaylova A, Baltadjieva D, Boneva P, Ivanova M, Penkova K, Marinova D, et al. Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays--single-center experience. Hum Immunol. 2006;67:787–94. - PubMed
    1. Panigrahi A, Gupta N, Siddiqui JA, Margoob A, Bhowmik D, Guleria S, et al. Post- transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss. Hum Immunol. 2007;68:362–7. - PubMed
    1. Van der Mast BJ, van Besouw NM, Witvliet MD, de Kuiper P, Smak Gregoor P, van Gelder T, et al. Formation of donor-specific human leukocyte antigen antibodies after kidney transplantation:correlation with acute rejection and tapering of immunosuppression. Transplantation. 2003;75:871–7. - PubMed
    1. Lee PC, Zhu L, Terasaki PI, Everly MJ. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss. Transplantation. 2009;88:568–74. - PubMed
    1. Cardarelli F, Saidman S, Theruvath T, Tolkoff-Rubin N, Cosimi AB, Pascual M. The problem of late allograft loss in kidney transplantation. Minerva Urol Nefrol. 2003;55:1–11. - PubMed

LinkOut - more resources